| |
|
|
| Year : 2008 | Volume
: 19
| Issue : 5 | Page : 721-729 |
|
| Acute Kidney Injury due to Rhabdomyolysis |
|
|
Rafael Siqueira Athayde Lima, Geraldo Bezerra da Silva Junior, Alexandre Braga Liborio, Elizabeth De Francesco Daher
Department of Internal Medicine, School of Medicine, Division of Nephrology, Hospital, Universitario Walter Cantídio, Universidade Federal do Ceara, Fortaleza, Ceara, Brazil
Click here for correspondence address and email
|
|
 |
|
 Abstract | | |
Rhabdomyolysis is a clinical and biochemical syndrome that occurs when skeletal muscle cells disrupt and release creatine phosphokinase (CK), lactate dehydrogenase (LDH), and myoglobin into the interstitial space and plasma. The main causes of rhabdomyolysis include direct muscular injury, strenuous exercise, drugs, toxins, infections, hyperthermia, seizures, metabolic and/or electrolyte abnormalities, and endocrinopathies. Acute kidney injury (AKI) occurs in 33-50% of patients with rhabdomyolysis. The main pathophysiological mechanisms of renal injury are renal vasoconstriction, intraluminal cast formation, and direct myoglobin toxicity. Rhabdomyolysis can be asymptomatic, present with mild symptoms such as elevation of muscular enzymes, or manifest as a severe syndrome with AKI and high mortality. Serum CK five times higher than the normal value usually confirms rhabdomyolysis. Early diagnosis and saline volume expansion may reduce the risk of AKI. Further studies are necessary to establish the importance of bicarbonate and mannitol in the prevention of AKI due to rhabdomyolysis. Keywords: Rhabdomyolysis, Myoglobin, Acute kidney injury, Pathophysiology, Treatment
How to cite this article:
Lima RA, da Silva Junior GB, Liborio AB, Daher ED. Acute Kidney Injury due to Rhabdomyolysis. Saudi J Kidney Dis Transpl 2008;19:721-9 |
How to cite this URL:
Lima RA, da Silva Junior GB, Liborio AB, Daher ED. Acute Kidney Injury due to Rhabdomyolysis. Saudi J Kidney Dis Transpl [serial online] 2008 [cited 2022 Jun 29];19:721-9. Available from: https://www.sjkdt.org/text.asp?2008/19/5/721/42439 |
| Introduction | |  |
Rhabdomyolysis is a syndrome that occurs when skeletal muscle cells disrupt and release creatine phosphokinase (CK), lactate dehydrogenase (LDH), and myoglobin into the interstitial space and plasma.
Acute kidney injury (AKI) occurs in 33–50% of patients with rhabdomyolysis, and it is the main cause of mortality in them. [1],[2] AKI due to rhabdomyolysis was first described by Bywaters and Beall [3] during the 2nd World War, and called it the "crush syndrome". After London bombings, the rubbles survivors suffered from hypovolemic shock and dark urine.
The main causes of rhabdomyolysis include direct muscular injury, strenuous exercise, drugs, toxins, infections, hyperthermia, seizures, metabolic, and/or electrolyte abnormalities and endocrinopathies. [4],[5],[6] Risk factors that predis poses to rhabdomyolysis include older age, inflammatory muscular diseases, renal failure, and hypothyroidism. [7]
Rhabdomyolysis can be asymptomatic, present with mild symptoms such as elevation of muscular enzymes, or manifest as a severe syndrome with AKI and high mortality.
| Pathophysiology | | |
Causes of rhabdomyolysis usually result in destruction of muscle cells and consequent release of intracellular contents into extracellular fluid or circulation. When cells are subjected to mechanical stress, there is influx of sodium and calcium into the cell, which causes several pathologic processes due to the excess of calcium. Excessive intracellular calcium results in persistent contraction of the myofibers, depletion of adenosine triphosphate (ATP), production of free radicals, activation of vasoactive molecules, release of proteases, and ultimately cell death. Afterwards, neutrophils invade and amplify the damage with release of proteases and augmented production of free radicals, and a self-sustaining, inflammatory myolytic reaction develops. [8]
The main mechanism of muscular injury is associated with a reperfusion process. [9] After a period of ischemia and reestablishment of tissue perfusion, migration of leukocytes and production of free radicals occurs. Compartmental syndrome also contributes to the pathophysiology of rhabdomyolysis, since most muscle groups are contained within rigid fascial compartments, and swelling by the 3 rd spacing of fluids associated with a traumatized muscular tissue can result in increased intracompartmental pressure that can cause additional damage by compromising both venous and arterial blood flow. [9]
Different mechanisms are associated with AKI due to rhabdomyolysis such as hypovolemia, intraluminal obstruction by myoglobin, uric acid casts, direct myoglobin toxicity, renal ischemia secondary to muscular vasoconstrictors, and production of free radicals. [4],[10],[11]
Myoglobin released from lysis of muscular cells does not have a specific binding protein, and it is freely filtered by the glomeruli. Myoglobin levels return to normal values in 1–6 hours after injury due to hepatic metabolism and renal excretion. [12] Casts are produced after filtration of myoglobin through the glomerular basement membrane. Water reabsorption causes rise of myoglobin concentration, and in the presence of acid urine, myoglobin precipitates and forms obstructive casts. [4] Moreover, myoglobin can, through the heme fraction, induce the release of free iron, which catalyses free radical production and further enhances ischemic tubule damage. In the absence of hypovolemia and acid urine, myoglobin has a less nephrotoxic effect. [13],[14]
Another factor that can exacerbate tubular obstruction is the disseminated intravascular coagulopathy associated with rhabdomyolysis due to activation of the coagulation cascade by the substances released from damaged muscle cells. [4],[15],[16]
The factors associated with AKI due to rhabdomyolysis are presented in [Figure 1].
| Etiology | | |
There are numerous causes of rhabdomyolysis. Sulowicz et al [6] found the following causes among 81 patients: trauma (49%), hypothermia (18%), seizures (17%), and strenous exercise (1%).
Strenous exercise
Extreme physical activity can result in muscular disintegration and release of muscular constituents into the extracellular fluid and circulation. Strenuous muscular exercise seems to play a decisive role in the pathogenesis of rhabdomyolysis, especially in untrained people or in individuals experiencing it in extremely hot or humid conditions. [15],[17],[18] Similar process is found in the "raver´s hematuria", which occurs in people who dance for hours, usually with concomitant ingestion of amphetamines, and develop rhabdomyolysis and hematuria. [19]
Compartmental syndrome
Compartment syndrome can result in hypo volemic shock and AKI. [4],[10],[20] Compartmental syndrome should be suspected in patients presenting with swollen legs, as illustrated in [Figure 2]. In non-traumatic obese patients may suffer from muscle compression during elective surgery because of unsuitable positioning or tourniquet use. [21],[22] Mognol et al [23] found an incidence of 22.7% for rhabdomyolysis in obese patients undergoing laparoscopic gastric banding or gastric bypass, and they identified the duration of the operation as an important risk factor for rhabdomyolysis in such patients. Bostanjian et al [24] suggest routine measurement of CK levels immediately postoperatively and then daily, until the values reveal clear trend to normality.
Drugs
Rhabdomyolysis can be caused by diverse drugs such as statins with incidence in 1ndash;5% of patients who ingest this drugs. [25] The mechanism of rhabomyolysis associated with the use of statins is not completely understood, and it involves depletion of the intermediary metabolites of cholesterol synthesis, cellular apoptosis induction, and alterations in conductance of chloride channels in the myocytes. [7]
Atorvastatine, lovastatine and simvastatine induce apoptosis of muscular cells in a dosedependent mechanism, [26] and the association of the statins with other drugs such as fibrates, nicotinic acid, cyclosporine, antifungal, macrolides, amoxicillin, protease inhibitors, nefazodone, verapamil, amiodarone, and chlopidogrel increases the risk of rhabdomyolysis due to a synergistic myotoxic effect or by increasing the serum levels of statines. [27],[28],[29],[30],[31],[32],[33],[34] The proposed risk factors for statin-induced rhabdomyolysis are shown in [Table 2]. [35]
Muscular symptoms can start at any time during treatment with statins, but usually one to four weeks after the start of these drugs. [36] After 3–30 days of withdrawal of statins the muscular symptoms usually decrease, and the CK normalizes. [36] Although this risk of myopathy during the use of statins is established, the routine monitorization of CK and transaminases is not recommended. However, patients must be alerted about the possibility of muscular weakness and myalgia. [37],[38]
Moreover, cases of AKI and rhabdomyolysis have been described in patients using haloperidol and other neuroleptics, presenting as neuroleptic malignant syndrome. [39] Tuccori et al [40] described an 85-year-old diabetic woman with gabapentin-induced severe myopathy (CK: 3095 U/L, myoglobin: 17000 mg/dL, and creatinine: 4.77 mg/dL).
Metabolic Disorders
The McArdle´s disease, an autossomal recessive metabolic disorder, was first described in 1951. [41] There is myophosphorylase deficiency in type II muscular fibers leading to ATP depletion and myonecrosis during physical exercise. [42] The disease was described in patients who developed rhabdomyolysis after heavy muscular exercise and an asthmatic attack. [43],[44]
Electrolyte abnormalities such as hypophosphatemia may contribute for muscular cellular lysis in the presence of previous muscular injury. Chronic hypophosphatemia can cause myopathy, but the isolated association with rhabdomyolysis is rare. Furthermore, hypophosphatemia and hypocalemia are risk factors for alcohol myotoxicity. [45]
Infections
Although only 5% of cases of rhabdomyolysis may be due to infections, [46] there are many agents involved. Infections by Influenza A and B virus are known causes of rhabdomyolysis. [47],[48] The most frequent bacteria that can cause rhabdomyolysis include Legionellae, Streptococcus, Salmonella More Details and Francisella tularensis. [49]
Toxins
The venom of wasps, hornets and yellow jackets contains a wide spectrum of peptides, amines, and enzymes that are responsible for the local and systemic effects. Allergic manifestations to honeybee and wasp stings are well recognized, however, more serious complications like anaphylaxis, intravascular hemolytic, rhabdomyolysis, thrombocytopenia, acute renal failure, liver impairment, and myocardial infarction are less common. [50],[51]
Daher et al [52] described two patients with almost 600 and 1500 honeybee (Apis Mellifera) stings, respectively. The most frequent clinical findings were generalized edema, arterial hypotension, hemolysis, rhabdomyolysis and acute renal failure. Moreover, Koya et al [53] reported a 59–year-old patient who developed rhabdomyolysis and AKI after extensive red fire ant bites. AKI is usually due to a toxic-ischemic mechanism that includes hypovolemia, myoglobinuria, hemoglobinuria, renal ischemia, and direct venom toxicity. [54],[55]
Intoxication
Non-traumatic rhabdomyolysis is usually caused by a toxic reaction to drugs. Talaie et al [56] found that among 143 patients with rhabdomyolysis due to poisoning the most common cause was opium, and in 7% of the cases with multiple drug poisoning AKI was predominant.
Electrolyte abnormalities caused by alcohol ingestion are also important in causing muscle damage. Ethanol intoxication, for instance, can cause water-electrolyte and acid-base disturbances such as metabolic acidosis, hypomagnesemia, hypocalcemia, and hypophosphatemia, which can result in muscular cytolysis. [6]
Moreover, rhabdomyolysis is very common after cocaine use, because of prolonged vasoconstriction that causes muscle ischemia. [57] Blood pressure frequently rises after using cocaine and it appears to contribute towards the development of rhabdomyolysis.
| Clinical and Laboratory Evaluation | | |
Patients with rhabdomyolysis can present with increased body temperature, muscular weakness, generalized or localized myalgia, edema and dark brown urine. [58],[59] The spectrum of muscle toxicity is described in [Table 3].
Laboratory findings include urine dipstick positive for blood in the absence of urinary erythrocytes, myoglobinuria, granular casts, epithelial cells in the sediment, and elevated muscle enzymes levels in the serum such as CK, LDH, and aspartate and alanine aminotransferases (AST, ALT), besides elevated serum phosphate and potassium serum levels and initially low serum calcium concentration. [15],[60] Serum CK, AST, ALT, and LDH levels correlate with the extent of muscular damage. However, these findings have no prognostic value. [12]
Rhabdomyolysis can easily be confused with the diagnosis of deep vein thrombosis when the patient presents with acutely swollen and painful legs and an absence of pulse in the foot. [60]
Myoglobin is quickly filtered and excreted until renal failure limits its excretion, and contributes to the brownish urine color. [12],[61]
Elevated serum CK levels are enough to establish the diagnosis of rhabdomyolysis. A five times higher than the normal value CK increase confirm the diagnosis of rhabdomyolysis. [1],[10] Maximum CK concentration is usually reached during the first 24 hours in 70% of the cases. [11] Serum myoglobin higher than 30 µg/mL also confirms rhabdomyolysis. [10]
Magnetic resonance image (MRI) is the method of choice to evaluate the distribution and extension of the affected muscles, especially when fasciotomy is considered for treatment. Even though MRI findings are nonspecific, the sensitivity in the detection of muscle involvement is higher than that of computed tomography or ultrasound. [62]
Rhabdomyolysis can also be diagnosed with a muscle biopsy. The histopathologic findings usually include loss of cell nucleus and muscular stria with absence of inflammatory cells. [63]
| Treatment | | |
Treatment should be instituted immediately in order to modify the factors that cause AKI, such as volume depletion, tubular obstruction, aciduria, and release of free radicals. [4] The prognosis is usually excellent if the underlying mechanism of rhabdomyolysis can be identified and reversed, whenever it is possible. [15]
There is a consensus for intravascular volume expansion by using saline solution and mannitol to maintain urine output at more than 200300 ml/hour. [15] Alkalization of urine can be attempted to reduce the formation of myoglobin casts in renal tubules. [15] In an experimental study, [64] the association of saline solution, sodium bicarbonate, and mannitol was more effective than hypertonic saline-dextran in decreasing oxidant injury in rhabdomyolysis. Accordingly, if CK exceeds 5,000 IU/L it is advisable to institute aggressive venous hydration, prophylactic bicarbonate and mannitol. Better et al [65] advocate the administration of saline solution (1.5 L/h) as soon as possible in traumatic cases of rhabdomyolysis. Furthermore, Altintepe et al [66] concluded that the rapid fluid therapy accompanied by the prophylactic administration of mannitol-bicarbonate are largely effective in preventing the development of AKI in cases of crush syndrome.
On the other hand, Brown et al [67] performed a study with 2,083 patients with post-traumatic rhabdomyolysis in intensive care unit and concluded that the administration of bicarbonate and mannitol should be reevaluated since they did not prevent renal failure (creatinine > 2.0 mg/dL), dialysis, or mortality in patients with CK levels greater than 5,000 U/L.
In summary, rhabdomyolysis is an important medical problem that can be found in different clinical settings and should be rapidly recognized in order to provide an adequate treatment. Early diagnosis and volume expansion usually reduce the risk of AKI. Further studies are necessary to establish the importance of bicarbonate and mannitol in the prevention of AKI and reduction of mortality due to rhabdomyolysis.[Table 1]
| References | | |
| 1. | Torres-Villalobos G, Kimura E, Mosqueda JL, Garcia-Garcia E, Dominguez-Cherit G, Herrera MF. Pressure induced rhabdomyolysis after bariatric surgery. Obes Surg 2003;13(2):297-301.  |
| 2. | Zager RA. Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury. Lab Invest 1989;60(5):619-29. |
| 3. | Bywaters EG, Beall D. Crush injuries with impairment of renal function. Br Med J 1941; 1:427-32. |
| 4. | Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol 2000;11 (8):1553-61. |
| 5. | Haas CE, Magram Y, Mishra A. Rhabdomyolysis and acute renal failure following an ethanol and diphenhydramine overdose. Ann Pharmacother 2003;37(4):538-42. |
| 6. | Sulowicz W, Walatek B, Sydor A, et al. Acute renal failure in patients with rhabdomyolysis. Med Sci Monit 2002;8(1):CR24-7. |
| 7. | Jamal SM, Eisenberg MD, Christopoulos S. Rhabdomyolysis associated with hydroximethylglutaryl-coenzyme A reductase inhibitors. Am Heart J 2004;147(6):956-65. |
| 8. | O'Connor FG, Deuster PA. Rhabdomyolysis. In: Goldman L, Ausiello D, (eds). Cecil Medicine. Oxford: Elsevier-Saunders, 23 rd ed, 2007. |
| 9. | Odeh M. The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Eng J Med 1991;324(20):1417-22. |
| 10. | Rosa EC, Liberatori Filho AW, Schor N, Lopes AC. Rhabdomyolysis and acute kidney failure. Rev Assoc Med Bras 1996;42(1):39-45. |
| 11. | Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med 2001;27(5):803-11. |
| 12. | Lopez JR, Rojas B, Gonzalez MA, Terzic A. Myoplasmic Ca2+ concentration during exertional rhabdomyolysis. Lancet 1995;345 (8947):424-5. |
| 13. | Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49(2):314-26. |
| 14. | Daher EF, Cordeiro NF. Acute renal failure due to rhabdomyolysis. Rev Bras Med 1998;55 (7):526-33. |
| 15. | Lane R, Phillips M. Rhabdomyolysis. BMJ 2003;327(7407):115-6. |
| 16. | Better OS, Stein JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Eng J Med 1990; 322(12):825-9. |
| 17. | Knochel JP. Catastrophic medical events with exhaustive exercise: "White collar rhabdomyolysis". Kidney Int 1990;38(4):709-19. |
| 18. | Daher EF, Silva Junior GB, Brunetta DM, Pontes LB, Bezerra GP. Rhabdomyolysis and acute renal failure after strenuous exercise and alcohol abuse: Case report and literature review. Sao Paulo Med J 2005;123(1):33-7. |
| 19. | Sultana SR, Byrne DJ. 'Raver´s' haematuria. J R Coll Surg Edinb 1996;41(6):419-20. |
| 20. | Bocca G, van Moorselaar JA, Feitz WF, van der Staak FH, Monnens LA. Compartment syndrome, rhabdomyolysis and risk of acute renal failure as complications of the lithotomy position. J Nephrol 2002;15(2):183-5. |
| 21. | Khurana RN, Baudendistel TE, Morgan EF, Rabkin RA, Elkin RB, Aalami OO. Postoperative rhabdomyolysis following laparoscopic gastric bypass in the morbidly obese. Arch Surg 2004;139(1):73-6. |
| 22. | Karcher C, Dieterich HJ, Schroeder TH. Rhabdomyolysis in an obese patient after total knee arthroplasty. Br J Anaesth 2006;97(6): 822-4. |
| 23. | Mognol P, Vignes S, Chosidow D, Marmuse JP. Rhabdomyolysis after laparoscopic bariatric surgery. Obes Surg 2004;14(1):91-4. |
| 24. | Bostanjian D, Anthone GJ, Hamoui N, Crookes PF. Rhabdomyolysis of gluteal muscles leading to renal failure: a potentially fatal complication of surgery in the morbidly obese. Obes Surg 2003;13(2):302-5. |
| 25. | Pasternak RC, Smith SC Jr, Bairey-Merz CN, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002;40(3):567-72. |
| 26. | Knapp AC, Huang J, Starling G. Inhibition of HMGCoA reductase sensitize human smooth muscle cells to FAZ-ligand and cytokine induced cell death. Atherosclerosis 2000;152 (1):217-27. |
| 27. | Burton JR, Burton I, Pearson GJ. Clopidogrelprecipitated rhabdomyolysis in a stable heart transplant patient. Ann Pharmacother 2007;41 (1):133-7. |
| 28. | Shaukat A, Benekli M, Vladutiu GD, Slack JL, Wetzler M, Baer MR. Simvastatin-fluconazole causing rhabdomyolysis. Ann Pharmacother 2003;37(7-8):1032-5. |
| 29. | Molden E, Andersson KS. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients. Pharmacotherapy 2007;27(4):603-7. |
| 30. | Bhatia V. Massive rhabdomyolysis with simvastatin precipitated by amoxicillin. J Postgrad Med 2004;50(3):234-5. |
| 31. | Skrabal MZ, Stading JA, Monaghan MS. Rhabdomyolysis associated with simvastatinnefazodone therapy. South Med J 2003;96 (10):1034-5. |
| 32. | Roten L, Schoenenberger RA, Krahenbuhl S, Schlienger RG. Rhabdomyolysis in association with simvastatin and amiodarone. Ann Pharmacother 2004;38(6):978-81. |
| 33. | Schmidt GA, Hoehns JD, Purcell JL, Friedman RL, Elhawi Y. Severe rhabdomyolysis and acute renal. failure secondary to concomitant use of simvastatin, amiodarone and atazanavir. J Am Board Fam Med 2007;20(4):411-6. |
| 34. | Rosenson RS. Current overview of statininduced myopathy. Am J Med 2004;116(6): 408-16. |
| 35. | Antons KA, Williams CD, Baker SK, Phillips PS. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 2006;119(5):400-9. |
| 36. | Miller ML. Rhabdomyolysis. Up to Date 2004. Available at |
| 37. | Grundy SM. Can statins cause chronic lowgrade myopathy? Ann Intern Med 2002;137 (7):617-8. |
| 38. | Phillips PS, Haas RH, Bannykh S, et al. Statinassociated myopathy with normal creatine kinase levels. Ann Intern Med 2002;137 (7):581-5. |
| 39. | Korzets Z, Zelter E, Bernheim J. Acute renal failure in the setting of the neuroleptic malignant syndrome. Nephrol Dial Transplant 1996;11(5):885-6. |
| 40. | Tuccori M, Lombardo G, Lapi F, Vannacci A, Blandizzi C, Del Tacca M. Gabapentininduced severe myopathy. Ann Pharmacother 2007;41(7):1301-5. |
| 41. | McArdle B, Verdi D. Myopathy due to defect in muscle glycogen breakdown. Clin Sci 1951; 10:13-35. |
| 42. | Andreu AL, Nogales-Gadea G, Cassandrini D, Arenas J, Bruno C. McArdle disease: Molecular genetic update. Acta Myol 2007;26(1): 53-7. |
| 43. | Deliba0 A, Bek K, Ezgu FS, Demircin G, Oksal A, Oner A. Acute renal failure due to rhabdomyolysis in a child with McArdle disease. Eur J Pediatr 2007; Sep 26 [Epub ahead of print] |
| 44. | Tsushima K, Koyama S, Ueno M, et al. Rhabdomyolysis triggered by an asthmatic attack in a patient with McArdle disease. Intern Med 2001;40(2):131-4. |
| 45. | Knochel JP. Mechanisms of rhabdomyolysis. Curr Opin Reumatol 1993;5(6):725-31. |
| 46. | Aouina H, A3ssa I, Baccar MA, Gharbi L, Azzabi S, Bouacha H. Acute rhabdomyolysis during pneumococcal pneumonia: two cases. Rev Pneumol Clin 2007;63(2):105-8. |
| 47. | Abe M, Higuchi T, Okada K, Kaizu K, Matsumoto K. Clinical study of influenzaassociated rhabdomyolysis with acute renal failure. Clin Nephrol 2006;66(3):166-70. |
| 48. | Naderi AS, Palmer BF. Rhabdomyolysis and acute renal failure associated with influenza virus type B infection. Am J Med Sci 2006;3 32(2):88-9. |
| 49. | Viswerswaran P, Guntupalli J. Rhabdomyolysis. Crit Care Clin 1999;15(2):415-28. |
| 50. | Subramanian C, Jain V, Singh M, Kumar L. Allergic and systemic reactions following yellow jacket stings. Indian Pediatr 2000;37(9):1003-5. |
| 51. | Thiruventhiran T, Goh BL, Leong CL, Cheah PL, Looi LM, Tan SY. Acute renal failure following multiple wasp stings. Nephrol Dial Transplant 1999;14(1):214-7. |
| 52. | Daher EF, Silva Junior GB, Bezerra GP, Pontes LB, Martins AM, Guimaraes JA. Acute renal failure after massive honeybee stings. Rev Inst Med Trop Sao Paulo 2003;45(1):45-50. |
| 53. | Koya S, Crenshaw D, Agarwal A. Rhabdomyolysis and acute renal failure after fire ant bites. J Gen Intern Med 2007;22(1):145-7. |
| 54. | Nace L, Bauer P, Lelarge P, Bollaert PE, Larcan A, Lambert H. Multiple European wasp stings and acute renal failure. Nephron 1992; 61(4):477. |
| 55. | Sitprija V, Boonpuknavig V. Renal failure and myonecrosis following wasp sting. Lancet 1972;1(7753):749-50. |
| 56. | Talaie H, Pajouhmand A, Abdollahi M, et al. Rhabdomyolysis among acute human poisoning cases. Hum Exp Toxicol 2007;26(7):557-61. |
| 57. | Crowe AV, Howse M, Bell GM, Henry JA. Substance abuse and the kidney. Q J Med 2000;93(3):147-52. |
| 58. | Minigh JL, Valentovic MA. Characterization of myoglobin toxicity in renal cortical slices from Fischer 344 rats. Toxicology 2003;184(23):113-23. |
| 59. | Hojs R, Ekart R, Sinkovic A, Hojs-Fabjan T. Rhabdomyolysis and acute renal failure in the intensive care unit. Ren Fail 1999;21(6):675-84. |
| 60. | Mallinson RH, Goldsmith DJ, Higgins RM, Venning MC, Ackrill P. Acute swollen legs due to rhabdomyolysis: Initial management as deep vein thrombosis may lead to acute renal failure. BMJ 1994;309(6965):1361-2. |
| 61. | Burton D. Clinical features and treatment of heme pigment-induced acute tubular necrosis. UpToDate 2004. Available at |
| 62. | Moratalla MB, Braun P, Fornas GM. Importance of MRI in the diagnosis and treatment of rhabdomyolysis. Eur J Radiol 2008;65(2):311-5. |
| 63. | Hino I, Akama H, Furuya T. Pravastatininduced rhabdomyolysis in a patient with mixed connective tissue disease. Arthritis Rheum 1996;39(7):1259-61. |
| 64. | Ozguc H, Kahveci N, Akkose S, Serdar Z, Balci V, Ocak O. Effects of different resuscitation fluids on tissue blood flow and oxidant injury in experimental rhabdomyolysis. Crit Care Med 2005;33(11):2579-86. |
| 65. | Better OS, Stein JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Eng J Med 1990; 322(12):825-9. |
| 66. | Altintepe L, Guney I, Tonbul Z, et al. Early and intensive fluid replacement prevents acute renal failure in the crush cases associated with spontaneous collapse of an apartment in Konya. Ren Fail 2007;29(6):737-41. |
| 67. | Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma 2004;56(6):1191-6. |
Correspondence Address:
Elizabeth De Francesco Daher
Rua Vicente Linhares, 1198. Fortaleza, CE, Brazil - CEP: 60270-135
Brazil
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 18711286 
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3] |
|
| This article has been cited by | | 1 |
A case of flax seed induced rhabdomyolysis |
|
| Prasad, A. and Kumar, R. and Ramanan, H. and Khandige, N. and Prabhu, K. | | Journal of Clinical and Diagnostic Research. 2012; 6(10): 1770-1771 | | [Pubmed] | | | 2 |
Rhabdomyolysis due to multiple fire ant bites a case report |
|
| Prasad, A. and Kumar, R. and Ramanan, H. and Khandige, N. and Prabhu, K. | | Asian Pacific Journal of Tropical Disease. 2012; 2(5): 417-418 | | [Pubmed] | | | 3 |
A case of lethal soft tissue injuries due to assault |
|
| Yanagawa, Y. and Kanawaku, Y. and Kanetake, J. | | Open Access Emergency Medicine. 2012; 4: 17-19 | | [Pubmed] | | | 4 |
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide |
|
| Donato, V. and Noto, A. and Lacquaniti, A. and Bolignano, D. and Versaci, A. and David, A. and Spinelli, F. and Buemi, M. | | American Journal of Critical Care. 2011; 20(5): 405-409 | | [Pubmed] | | | 5 |
Hyperkalemia in a patient with rhabdomyolysis and compartment syndrome |
|
| Park, S.E. and Kim, D.-Y. and Park, E.-S. | | Korean Journal of Anesthesiology. 2010; 59(SUPPL.): S37-S40 | | [Pubmed] | | | 6 |
R2 syndrome: Religion and renal failure |
|
| Gupta, A. and Lal, C. and Khaira, A. and Agarwal, S.K. and Tiwari, S.C. | | Journal of Association of Physicians of India. 2010; 58(3): 201 | | [Pubmed] | | | 7 |
Role of dipstick in detection of haeme pigment due to rhabdomyolysis in victims of bam earthquake [Rôle des bandelettes réactives dans la détection du pigment hémique lié à la rhabdomyolyse chez les victimes du tremblement de terre de bam] |
|
| Amini, M. and Sharifi, A. and Najafi, I. and Eghtesadi-Araghi, P. and Rasouli, M.R. | | Eastern Mediterranean Health Journal. 2010; 16(9) | | [Pubmed] | | | 8 |
Acute kidney injury due to rhabdomyolysis-associated gangrenous myositis |
|
| Daher, E.D.F. and Lima, R.S.A. and Silva Jr., G.B. and Almeida, J.P.C. and Siqueira, F.J.W.S. and Santos, S.Q. and Silva, S.W. and Libório, A.B. | | Acta Biomedica de læAteneo Parmense. 2008; 79(3): 246-250 | | [Pubmed] | |
|
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 25084 | | | Printed | 452 | | | Emailed | 0 | | | PDF Downloaded | 4622 | | | Comments | [Add] | | | Cited by others | 8 | | |
|
|
